Oncology Institute earnings were -$55.0M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest TOI earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$16.1M, up 4.1% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, TOI reported annual earnings of -$67.9M, with -99,919.1% growth.
What were Oncology Institute's earnings last quarter?
On TOI's earnings call on Invalid Date, Oncology Institute (NASDAQ: TOI) reported Q3 2024 earnings per share (EPS) of -$0.18, up 5.26% year over year. Total TOI earnings for the quarter were -$16.11 million. In the same quarter last year, Oncology Institute's earnings per share (EPS) was -$0.19.
As of the last Oncology Institute earnings report, Oncology Institute is currently losing money. Oncology Institute's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$55.04 million, a 27% decrease year over year.
What was TOI's earnings growth in the past year?
As of Oncology Institute's earnings date in Invalid Date, Oncology Institute's earnings has grown year over year. TOI earnings in the past year totalled -$55.04 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.